Jan 6, 2022 6:00 am EST BioRestorative Therapies to Present at H.C. Wainwright BioConnect Virtual Conference
Jan 4, 2022 6:00 am EST BioRestorative Therapies Awarded an STTR Phase I Grant to Explore the Therapeutic Effects of PEG-Peptide Hydrogel-Encapsulated Hypoxic Bone Marrow Stem Cells
Dec 21, 2021 4:01 pm EST BioRestorative Therapies Announces CRO Agreement with PRC Clinical for its BRTX-100 Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease
Dec 21, 2021 6:00 am EST BioRestorative Therapies CEO Interviewing Live on the James Hicks NewMedia Show
Dec 2, 2021 6:00 am EST BioRestorative Therapies Announces Filing of Ten Patent Applications Related to its BRTX-100 Program
Nov 4, 2021 9:21 pm EDT BioRestorative Therapies Prices $23 Million Public Offering and Uplisting to the Nasdaq Capital Market